Breaking News Instant updates and real-time market news.

XENE

Xenon Pharmaceuticals

$12.20

(0.00%)

06:11
08/29/18
08/29
06:11
08/29/18
06:11

Xenon Pharmaceuticals' XEN1101 shows 'positive' results in Phase 1b study

Xenon Pharmaceuticals announced 'positive' data from its XEN1101 Phase 1b transcranial magnetic stimulation study. XEN1101 is a Kv7 potassium channel opener being developed by Xenon for the treatment of epilepsy. Results will be presented in a podium presentation at the 13th European Congress on Epileptology being held in Vienna. The completed Phase 1b TMS study suggested XEN1101 has an ability to inhibit cortical excitability, an important CNS effect observed with approved anti-epileptic drugs. XEN1101 was well tolerated with all adverse events reported as mild or moderate and reversible. In addition to completing both the Phase 1a pilot and Phase 1b TMS studies, Xenon has now completed enrollment in the XEN1101 Phase 1 clinical trial using a powder-in-capsule formulation, which is evaluating the safety, tolerability and pharmacokinetics of both single ascending doses and multiple ascending doses of XEN1101. A Phase 2 clinical trial in adult focal seizures expected to be initiated in Q4.

XENE Xenon Pharmaceuticals
$12.20

(0.00%)

03/22/18
JEFF
03/22/18
NO CHANGE
Target $6
JEFF
Buy
Xenon Pharmaceuticals price target raised to $6 from $5 at Jefferies
Jefferies analyst Maury Raycroft raised his price target for Xenon Pharmaceuticals to $6 and keeps a Buy rating on the shares after traveling with management. The analyst sees 2018 as a key year for the company with data readouts in epilepsy. Initial data in May will likely move the stock, Raycroft tells investors in a research note.
06/13/18
JEFF
06/13/18
NO CHANGE
Target $9
JEFF
Buy
Sage update yesterday positive for Xenon, says Jefferies
Jefferies analyst Maury Raycroft believes Sage Therapeutics' (SAGE) FDA approval to accelerate a development path for '217 in major depressive disorder and postpartum depression provides a positive read-through for Xenon Pharmaceuticals (XENE). Xenon has two epilepsy programs and one program for hemiplegic migraine, which all have potential in rare disease indications with broader applicability, Raycroft tells investors in a research note. He believes "recent derisking" provides a "great entry point" into Xenon Pharmaceuticals at current share levels. The analyst has a Buy rating on the shares with a $9 price target.

TODAY'S FREE FLY STORIES

MU

Micron

$34.81

0.92 (2.71%)

, UMC

UMC

$1.81

-0.005 (-0.28%)

13:50
12/18/18
12/18
13:50
12/18/18
13:50
On The Fly
Fly Intel: What to watch for in Micron's earnings report »

Micron (MU) is scheduled…

MU

Micron

$34.81

0.92 (2.71%)

UMC

UMC

$1.81

-0.005 (-0.28%)

INTC

Intel

$48.04

0.95 (2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 04

    Jan

  • 07

    Jan

  • 08

    Jan

VOD

Vodafone

$19.88

-0.13 (-0.65%)

13:48
12/18/18
12/18
13:48
12/18/18
13:48
Periodicals
Vodafone preparing to remove PwC as auditor, Sky News reports »

Vodafone is preparing to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,057.23

30.69 (2.99%)

, GOOG

Alphabet

$1,046.01

28.41 (2.79%)

13:40
12/18/18
12/18
13:40
12/18/18
13:40
Periodicals
Search engine startup claims Google still blocking competition, TechCrunch says »

The European Commission…

GOOGL

Alphabet Class A

$1,057.23

30.69 (2.99%)

GOOG

Alphabet

$1,046.01

28.41 (2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

KMX

CarMax

$60.38

0.11 (0.18%)

13:40
12/18/18
12/18
13:40
12/18/18
13:40
Options
7X average daily option volume in CarMax driven by an earnings hedge »

7X average daily option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

  • 31

    Jan

  • 01

    Feb

BIDU

Baidu

$169.94

0.03 (0.02%)

13:35
12/18/18
12/18
13:35
12/18/18
13:35
Hot Stocks
Unity Technologies, Baidu partner to develop autonomous vehicle simulation »

Unity Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$131.11

2 (1.55%)

13:32
12/18/18
12/18
13:32
12/18/18
13:32
Periodicals
J&J settles woman's talc cancer case for over $1.5M, Bloomberg reports »

Johnson & Johnson,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 27

    Jan

ORGS

Orgenesis

$4.84

-0.11 (-2.22%)

13:31
12/18/18
12/18
13:31
12/18/18
13:31
Hot Stocks
Orgenesis announces collaboration with MangoGen Pharma »

Orgenesis announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNN

Smith & Nephew

$36.67

-0.38 (-1.03%)

13:27
12/18/18
12/18
13:27
12/18/18
13:27
Hot Stocks
Smith & Nephew buys Ceterix Orthopaedics for $50M initial consideration »

Smith & Nephew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALB

Albemarle

$81.62

1.12 (1.39%)

13:26
12/18/18
12/18
13:26
12/18/18
13:26
Hot Stocks
Albemarle higher after Hedgeye names new Best Idea Long »

Shares of Albemarle are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTWO

Take-Two

$104.09

1.87 (1.83%)

, ATVI

Activision Blizzard

$47.54

0.45 (0.96%)

13:24
12/18/18
12/18
13:24
12/18/18
13:24
On The Fly
Game On: Wedbush's Pachter says 'Red Dead 2' performing better than he expected »

SUCCESS OF 'RED DEAD 2':…

TTWO

Take-Two

$104.09

1.87 (1.83%)

ATVI

Activision Blizzard

$47.54

0.45 (0.96%)

EA

Electronic Arts

$81.22

2.01 (2.54%)

NTDOY

Nintendo

$0.00

(0.00%)

MSFT

Microsoft

$104.06

1.08 (1.05%)

SNE

Sony

$50.06

-0.425 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

  • 03

    Mar

  • 04

    Mar

13:20
12/18/18
12/18
13:20
12/18/18
13:20
Options
Put buying in PHLX Gold and Silver Mining Index as the sector sees strength »

Put buying in PHLX Gold…

APHA

Aphria

$5.98

0.54 (9.93%)

13:18
12/18/18
12/18
13:18
12/18/18
13:18
Hot Stocks
Citron expects 'major partnership or total buyout' soon for Aphria 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$6.01

0.57 (10.48%)

, IGC

India Globalization Capital

$0.00

(0.00%)

13:17
12/18/18
12/18
13:17
12/18/18
13:17
Hot Stocks
Citron mentions Aphria positively again, says 'everything changed' in cannabis 

Reference Link

APHA

Aphria

$6.01

0.57 (10.48%)

IGC

India Globalization Capital

$0.00

(0.00%)

CANN

General Cannabis

$0.00

(0.00%)

CGC

Canopy Growth

$29.00

-0.365 (-1.24%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

CRON

Cronos Group

$11.64

0.52 (4.68%)

TLRY

Tilray

$74.39

8.5 (12.90%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

ACB

Aurora Cannabis

$5.55

0.01 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$6.01

0.57 (10.48%)

13:17
12/18/18
12/18
13:17
12/18/18
13:17
Periodicals
Breaking Periodicals news story on Aphria »

Citron Research sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/18/18
12/18
13:17
12/18/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/18/18
12/18
13:16
12/18/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLSN

Nielsen

$24.98

-0.32 (-1.26%)

13:15
12/18/18
12/18
13:15
12/18/18
13:15
Options
Nielsen put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$12.56

-1.89 (-13.08%)

13:14
12/18/18
12/18
13:14
12/18/18
13:14
Hot Stocks
Vintage says Rent-A-Center termination invalid, sees merger pact as in effect »

Vintage Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

RCII

Rent-A-Center

$12.67

-1.78 (-12.32%)

13:13
12/18/18
12/18
13:13
12/18/18
13:13
Hot Stocks
Breaking Hot Stocks news story on Rent-A-Center »

Vintage Capital believes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

RCII

Rent-A-Center

$12.67

-1.78 (-12.32%)

13:12
12/18/18
12/18
13:12
12/18/18
13:12
Hot Stocks
Breaking Hot Stocks news story on Rent-A-Center »

Vintage Capital says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

ISCA

International Speedway

$43.26

0.12 (0.28%)

13:10
12/18/18
12/18
13:10
12/18/18
13:10
Periodicals
Billionaire John Henry interested in Nascar stake, Bloomberg reports »

Billionaire and Boston…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:10
12/18/18
12/18
13:10
12/18/18
13:10
General news
FOMC began its 2-day meeting amid myriad controversies »

FOMC began its 2-day…

RCII

Rent-A-Center

$12.72

-1.73 (-11.97%)

13:09
12/18/18
12/18
13:09
12/18/18
13:09
Upgrade
Rent-A-Center rating change  »

Rent-A-Center upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

CSCO

Cisco

$44.25

0.04 (0.09%)

, AAOI

Applied Optoelectronics

$16.24

-0.89 (-5.20%)

13:05
12/18/18
12/18
13:05
12/18/18
13:05
Recommendations
Cisco, Applied Optoelectronics, Finisar analyst commentary  »

Luxtera buyout negative…

CSCO

Cisco

$44.25

0.04 (0.09%)

AAOI

Applied Optoelectronics

$16.24

-0.89 (-5.20%)

FNSR

Finisar

$21.76

0.2 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 04

    Mar

APHA

Aphria

$5.87

0.43 (7.90%)

13:05
12/18/18
12/18
13:05
12/18/18
13:05
Options
Aphria call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.